This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Xinhai Jiang: Innovator in Cardiovascular and Anti-Inflammatory Medicaments
Introduction
Xinhai Jiang is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating cardiovascular and cerebrovascular diseases. His innovative work has led to the creation of a unique compound that holds promise for various therapeutic applications.
Latest Patents
Xinhai Jiang holds a patent for an indolo[2',3′:3,4]pyrido[2,1-b]quinazoline compound. This compound is represented by a general formula and is utilized in the manufacture of several formulations. These formulations include a medicament for treating cardiovascular and cerebrovascular diseases, a formulation for increasing the expression of AMPK, ABCA1, and SR-BI, and a formulation for activating nuclear receptors while inhibiting the activity of NLRP3, IL-1β, NF-κB, and MAPKs. Additionally, it is used in a formulation for promoting cellular cholesterol efflux and as a medicament for anti-inflammation. Jiang's patent represents a significant advancement in the field of medicinal compounds.
Career Highlights
Xinhai Jiang is affiliated with the Chinese Academy of Medical Sciences, where he conducts his research and development work. His career is marked by a commitment to advancing medical science through innovative research and the development of new therapeutic agents. His contributions have been recognized within the scientific community, and he continues to work on projects that aim to improve health outcomes.
Collaborations
Jiang collaborates with esteemed colleagues, including Shuyi Si and Yanni Xu. These collaborations enhance the research efforts at the Chinese Academy of Medical Sciences and contribute to the advancement of medical innovations.
Conclusion
Xinhai Jiang is a prominent inventor whose work in developing novel compounds for treating cardiovascular and inflammatory conditions showcases his dedication to medical science. His patent reflects a significant contribution to the field, and his ongoing research promises to yield further advancements in healthcare.